Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Inactivated Influenza Vaccine
NCT03898973Phase 4Withdrawn
- Sponsor
- Stanford University
- Start
- Apr 2019
- Primary completion
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by Stanford University. Planned start Apr 2019; status: withdrawn.
02
Drugs
Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03898973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898973.